BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12062364)

  • 1. Noninvasive assessment of the effects of nicorandil on left ventricular volumes and function in reperfused myocardial infarction.
    Watzinger N; Lund GK; Higgins CB; Chujo M; Saeed M
    Cardiovasc Res; 2002 Apr; 54(1):77-84. PubMed ID: 12062364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular remodeling after infarction: sequential MR imaging with oral nicorandil therapy in rat model.
    Saeed M; Watzinger N; Krombach GA; Lund GK; Wendland MF; Chujo M; Higgins CB
    Radiology; 2002 Sep; 224(3):830-7. PubMed ID: 12202722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of potassium-channel opener therapy on reperfused infarction in hypertrophied hearts: demonstration of preconditioning by using functional and contrast-enhanced magnetic resonance imaging.
    Schalla S; Higgins CB; Chujo M; Saeed M
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9(3):193-202. PubMed ID: 15378140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pool contrast-enhanced MRI detects suppression of microvascular permeability in early postinfarction reperfusion after nicorandil therapy.
    Krombach GA; Higgins CB; Chujo M; Saeed M
    Magn Reson Med; 2002 May; 47(5):896-902. PubMed ID: 11979568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of nicorandil therapy in ischemic myocardial injury by using contrast-enhanced and functional MR imaging.
    Lund GK; Higgins CB; Wendland MF; Watzinger N; Weinmann HJ; Saeed M
    Radiology; 2001 Dec; 221(3):676-82. PubMed ID: 11719662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling.
    Watzinger N; Lund GK; Higgins CB; Wendland MF; Weinmann HJ; Saeed M
    J Magn Reson Imaging; 2002 Dec; 16(6):633-40. PubMed ID: 12451576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term oral treatment with nicorandil prevents the progression of left ventricular hypertrophy and preserves viability.
    Schalla S; Higgins CB; Saeed M
    J Cardiovasc Pharmacol; 2005 Apr; 45(4):333-40. PubMed ID: 15772522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.
    Ito H; Taniyama Y; Iwakura K; Nishikawa N; Masuyama T; Kuzuya T; Hori M; Higashino Y; Fujii K; Minamino T
    J Am Coll Cardiol; 1999 Mar; 33(3):654-60. PubMed ID: 10080465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The study of vasodilative and antiischemic function of nicorandil in regional ischemia and reperfusion of rat heart in vivo].
    Pisarenko OI; Serebriakova LI; Tskitishvili OV; Nesterenko DA; Eremenko LT; Kosilko VP; Garanin VA
    Kardiologiia; 2008; 48(5):36-40. PubMed ID: 18537801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicorandil protects against lethal ischemic ventricular arrhythmias and up-regulates endothelial nitric oxide synthase expression and sulfonylurea receptor 2 mRNA in conscious rats with acute myocardial infarction.
    Horinaka S; Kobayashi N; Yabe A; Asakawa H; Yagi H; Mori Y; Tsubokou Y; Yoshida K; Nakano S; Matsuoka H
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):13-22. PubMed ID: 15115899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials.
    Kitakaze M; Asakura M; Kim J; Shintani Y; Asanuma H; Hamasaki T; Seguchi O; Myoishi M; Minamino T; Ohara T; Nagai Y; Nanto S; Watanabe K; Fukuzawa S; Hirayama A; Nakamura N; Kimura K; Fujii K; Ishihara M; Saito Y; Tomoike H; Kitamura S;
    Lancet; 2007 Oct; 370(9597):1483-93. PubMed ID: 17964349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardioprotective effects of K(ATP) channel opener nicorandil during ischemia/ reperfusion in dogs].
    Feng L; Qiu J; Ma J; Huang XB; Cha DG; Bin JP
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Mar; 17(3):157-60. PubMed ID: 15760526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nicorandil on cardiac sympathetic nerve activity after reperfusion therapy in patients with first anterior acute myocardial infarction.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):322-8. PubMed ID: 15791442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in left ventricular mass and volumes in patients receiving angiotensin-converting enzyme inhibitor therapy for left ventricular dysfunction after Q-wave myocardial infarction.
    Foster RE; Johnson DB; Barilla F; Blackwell GG; Orr R; Roney M; Stanley AW; Pohost GM; Dell'Italia LJ
    Am Heart J; 1998 Aug; 136(2):269-75. PubMed ID: 9704689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadomer-enhanced MR imaging in the detection of microvascular obstruction: alleviation with nicorandil therapy.
    Krombach GA; Higgins CB; Chujo M; Saeed M
    Radiology; 2005 Aug; 236(2):510-8. PubMed ID: 16040908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction.
    Ikeda N; Yasu T; Kubo N; Hashimoto S; Tsuruya Y; Fujii M; Kawakami M; Saito M
    Heart; 2004 Feb; 90(2):181-5. PubMed ID: 14729792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Effects of Nicorandil on Cardiac Function and Left Ventricular Remodeling in a Rat Model of Ischemic Heart Failure.
    Xing Y; Liu C; Wang H; Zhang X; Wang Y; Yue X; Li Z; Wang X; Zhang W
    Arch Med Res; 2018 Nov; 49(8):583-587. PubMed ID: 30580880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of spirapril-induced structural and functional changes after myocardial infarction in rats followed with magnetic resonance imaging.
    Zierhut W; Rudin M; Robertson E; Zerwes HG; Novosel D; Evenou JP; Stirnimann R; Hof RP
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):937-46. PubMed ID: 7687720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous nicorandil in conjunction with coronary reperfusion therapy is associated with better clinical and functional outcomes in patients with acute myocardial infarction.
    Sugimoto K; Ito H; Iwakura K; Ikushima M; Kato A; Kimura R; Tanaka K; Masuyama T; Ogihara T; Kawano S; Fujii K
    Circ J; 2003 Apr; 67(4):295-300. PubMed ID: 12655158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
    Markham A; Plosker GL; Goa KL
    Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.